New Information on Prevention Trials Available from NCI
Two new easy-to-read brochures about prevention clinical trials are now available in English and in Spanish as part of the NCI Clinical Trials Education Series:
If You Want to Find Ways to Prevent Cancer, Learn about Prevention Clinical Trials and Si piensa que no hay forma de prevenir el cáncer...Conozca los estudios clinicos are for people considering participation in a prevention clinical trial and are designed to be used in conjunction with a health care professional. The English version is available at http://cancer.gov/clinicaltrials/learning/about-prevention-trials; the Spanish version is available at http://cancer.gov/espanol/estudios-de-prevencion. These and other materials can be ordered online at https://pubs.cancer.gov/ncipl.
Elizalde Named Deputy Director for Management
David A. Elizalde was named deputy director for management (DDM) and executive officer for NCI, effective August 22. As DDM, Mr. Elizalde will lead the operations of the Office of Management, including facilitating and supporting implementation of NCI initiatives, such as the 2015 challenge goal, advanced technology initiative, and cancer bioinformatics grid (caBIG). Mr. Elizalde comes to NCI from the Centers for Medicare and Medicaid Services, where he served for the past 5 years as deputy director of the acquisition and grants group. While there, he gained extensive experience in managing acquisitions for the Medicare prescription drug discount card, information technology, and beneficiary marketing programs. Throughout his career, he has developed innovative and creative solutions to management challenges, and used staff resources and financial capital to provide superior customer service. Mr. Elizalde previously worked for the Department of Veterans Affairs and holds a bachelor's degree from Oklahoma State University, a law degree from Oklahoma City University, and a master of laws degree from DePaul University.
Future Directions for Cancer Screening Promotion
The September 1 special issue of Cancer, titled "Promoting Cancer Screening: Lessons Learned and Future Directions for Research and Practice," represents a collaborative effort by NCI, the American Cancer Society, and the Centers for Disease Control and Prevention (CDC) to identify lessons learned from more than 20 years of cancer screening research and promotion. The papers are intended to encourage and inform future intervention research and application efforts.
The authors point out that multilevel approaches to screening, such as telephone counseling and physician recommendation, offer the greatest potential for improving and sustaining screening rates and appropriate follow-up care. They also note that future intervention studies should include cost-effectiveness analyses and plans for dissemination, and add that it is not enough to promote the uptake of cancer screening tests - practitioners must effectively communicate the benefits and risks of screening tests, as well as test options and limitations, so that people can make informed decisions about cancer screening.
Behavioral scientists and other researchers can use the supplement, available at http://www3.interscience.wiley.com/cgi-bin/jissue/109594949, as a point from which to advance the next generation of research to promote cancer screening.
Radiation Oncology Sciences Program Staff Visit Capitol Hill
On August 17, Dr. C. Norman Coleman and staff from the NCI Radiation Oncology Sciences Program (ROSP) briefed the House Energy and Commerce Committee on the ROSP mission and its components. Staff members representing Rep. Michael Bilirakis (R-Fla.), Rep. Sherrod Brown (D-Ohio), and Rep. Chip Pickering (R-Miss.), and the American Society for Therapeutic Radiation Oncology attended.
The ROSP's intramural component provides clinical care and conducts basic and translational research on the use of imaging in radiation therapy and the effects of radiation on healthy and cancer cells. A highlight of the briefing was Dr. Kevin Camphausen's discussion of participant care in NCI-run clinical trials. Attendees also learned about the telesynergy program which increases minority access to and participation in radiation clinical trials, encourages research in cancer disparities, and develops new institutions within minority communities for long-term research efforts.
Reminder: Gerberding to Speak at NIH
On Thursday, September 16, at 1:00 p.m. in Building 10's Masur Auditorium on the NIH campus, Dr. Julie Louise Gerberding, director of CDC and administrator of the Agency for Toxic Substances and Disease Registry, will present an NCI Director's Seminar Series lecture titled, "Achieving Energy Balance: Aspiration...Inspiration...Motivation... Implementation!" The lecture will be Webcast live at http://videocast.nih.gov. Sign language interpreters will be provided. For more information go to http://cancer.gov/directorsseminarseries/Gerberding.